PH12019000231A1 - Palatable high sodium oral rehydration solution - Google Patents

Palatable high sodium oral rehydration solution

Info

Publication number
PH12019000231A1
PH12019000231A1 PH12019000231A PH12019000231A PH12019000231A1 PH 12019000231 A1 PH12019000231 A1 PH 12019000231A1 PH 12019000231 A PH12019000231 A PH 12019000231A PH 12019000231 A PH12019000231 A PH 12019000231A PH 12019000231 A1 PH12019000231 A1 PH 12019000231A1
Authority
PH
Philippines
Prior art keywords
high sodium
oral rehydration
rehydration solution
sodium oral
palatable
Prior art date
Application number
PH12019000231A
Inventor
Joyce Bedelia B Santos
Kennie U Dee
Original Assignee
Novex Science Pte Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Novex Science Pte Ltd filed Critical Novex Science Pte Ltd
Priority to PH12019000231A priority Critical patent/PH12019000231A1/en
Priority to PCT/IB2020/050331 priority patent/WO2020260959A2/en
Priority to TW109121946A priority patent/TW202114638A/en
Publication of PH12019000231A1 publication Critical patent/PH12019000231A1/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0087—Galenical forms not covered by A61K9/02 - A61K9/7023
    • A61K9/0095—Drinks; Beverages; Syrups; Compositions for reconstitution thereof, e.g. powders or tablets to be dispersed in a glass of water; Veterinary drenches
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/194—Carboxylic acids, e.g. valproic acid having two or more carboxyl groups, e.g. succinic, maleic or phthalic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7004—Monosaccharides having only carbon, hydrogen and oxygen atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/14—Alkali metal chlorides; Alkaline earth metal chlorides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/02—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/26—Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/08—Solutions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/12—Antidiarrhoeals
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs

Abstract

The present invention relates to a palatable high sodium oral rehydration solution that can be taken in large frequent doses.
PH12019000231A 2019-06-28 2019-06-28 Palatable high sodium oral rehydration solution PH12019000231A1 (en)

Priority Applications (3)

Application Number Priority Date Filing Date Title
PH12019000231A PH12019000231A1 (en) 2019-06-28 2019-06-28 Palatable high sodium oral rehydration solution
PCT/IB2020/050331 WO2020260959A2 (en) 2019-06-28 2020-01-16 Palatable high sodium oral rehydration solution
TW109121946A TW202114638A (en) 2019-06-28 2020-06-29 Palatable high sodium oral rehydration solution

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PH12019000231A PH12019000231A1 (en) 2019-06-28 2019-06-28 Palatable high sodium oral rehydration solution

Publications (1)

Publication Number Publication Date
PH12019000231A1 true PH12019000231A1 (en) 2021-01-11

Family

ID=74060772

Family Applications (1)

Application Number Title Priority Date Filing Date
PH12019000231A PH12019000231A1 (en) 2019-06-28 2019-06-28 Palatable high sodium oral rehydration solution

Country Status (3)

Country Link
PH (1) PH12019000231A1 (en)
TW (1) TW202114638A (en)
WO (1) WO2020260959A2 (en)

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP6274725B2 (en) * 2011-05-31 2018-02-07 サントリーホールディングス株式会社 Beverage composition
US10653168B2 (en) * 2013-06-12 2020-05-19 Sweetwater Solutions, LLC Oral rehydration solution with improved taste
JP6224489B2 (en) * 2014-03-07 2017-11-01 株式会社ヤクルト本社 Sodium-containing beverage
KR101911289B1 (en) * 2016-03-04 2018-10-24 노부토 와시오 Method and apparatus for manufacturing beverage and beverage products
KR20190061904A (en) * 2017-11-28 2019-06-05 이원철 Hangover relief by oral balanced fluid composition and method of preparing the same

Also Published As

Publication number Publication date
WO2020260959A2 (en) 2020-12-30
TW202114638A (en) 2021-04-16
WO2020260959A3 (en) 2021-04-15

Similar Documents

Publication Publication Date Title
CA171837S (en) Bus
AU2015208932A8 (en) (2S)-N-[(1S)-1-cyano-2-phenylethyl]-1,4-oxazepane-2-carboxamides as dipeptidyl peptidase I inhibitors
MY172578A (en) Oral dosing of glp-1 compounds
AU366476S (en) Bottle
GEP20207075B (en) New aminoacid derivatives, a process for their preparation and pharmaceutical compositions containing them
UY34678A (en) ADMINISTRATION OF OBJECTS IN A SUPPLY CHAIN, THROUGH THE USE OF A SAFE IDENTIFIER
CY1119694T1 (en) 5,10-Methylene- (6R) -tetrahydrofolic acid Sodium Sulphate
MX2015016676A (en) Stable oral solutions for combined api.
MX366368B (en) Prebiotic oral care methods using a saccharide.
PH12014502856B1 (en) Solid pharmaceutical preparation containing levothyroxine
MX2017001487A (en) Sofosbuvir in crystalline form and process for its preparation.
MX2020002123A (en) Ribociclib salts and solid state forms thereof.
IN2014MU00455A (en)
MX2017016588A (en) Novel triterpene-glycosides as sweeteners or sweetener enhancer.
MX2019001257A (en) Bioactive renal cells for the treatment of chronic kidney disease.
MY185823A (en) Method of production of gonadotrophin
MX2017009929A (en) Compositions and methods for improved muscle metabolism.
PH12017501602A1 (en) Solid oral care compositions
CO2019000604A2 (en) Vaginal composition comprising a combination of estrogen and vitamin D
MY194859A (en) Compositions and methods for enhancing immunity
PH12019000231A1 (en) Palatable high sodium oral rehydration solution
MX2016002638A (en) Oral rehydration compositions with galactooligosaccharides.
IN2013CH04314A (en)
MX2015009077A (en) Fingolimod containing stable composition.
PH12018500967A1 (en) Soy sauce-like seasoning